BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9928674)

  • 1. Modulation of sulfur mustard toxicity by arginine analogues and related nitric oxide synthase inhibitors in vitro.
    Sawyer TW
    Toxicol Sci; 1998 Nov; 46(1):112-23. PubMed ID: 9928674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic protective effects of selected arginine analogues against sulphur mustard toxicity in neuron culture.
    Sawyer TW
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):169-76. PubMed ID: 10053171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. l-thiocitrulline: A potent protective agent against the toxicity of sulphur mustard in vitro.
    Sawyer TW; Hancock JR; D'Agostino PA
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):340-6. PubMed ID: 9707510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selected arginine analogues on sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes.
    Sawyer TW; Risk D
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):75-85. PubMed ID: 10662607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of an inhibitor of nitric oxide synthase on sulphur mustard toxicity in vitro.
    Sawyer TW; Lundy PM; Weiss MT
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):138-44. PubMed ID: 8917686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of a role for creatine phosphate kinase in sulphur mustard-induced cytotoxicity.
    Nelson P; Burczyk A; Sawyer TW
    Hum Exp Toxicol; 2007 Nov; 26(11):891-7. PubMed ID: 18042583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
    Ichimori K; Stuehr DJ; Atkinson RN; King SB
    J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the protective effects of L-nitroarginine methyl ester (L-NAME) against the toxicity of sulphur mustard in vitro.
    Sawyer TW
    Toxicology; 1998 Nov; 131(1):21-32. PubMed ID: 9881932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological testing of potential heme-coordinating nitric oxide synthase inhibitors.
    Litzinger EA; Martásek P; Roman LJ; Silverman RB
    Bioorg Med Chem; 2006 May; 14(9):3185-98. PubMed ID: 16431112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone production in bovine luteal cells treated with drugs that modulate nitric oxide production.
    Jaroszewski JJ; Bogacki M; Skarzynski DJ
    Reproduction; 2003 Mar; 125(3):389-95. PubMed ID: 12611602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
    Cooper GR; Barr A; Wolff DJ
    Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal damage following intraspinal injection of a nitric oxide synthase inhibitor in the rat.
    Yezierski RP; Liu S; Ruenes GL; Busto R; Dietrich WD
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):996-1004. PubMed ID: 8784245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation.
    Korkmaz A; Yaren H; Topal T; Oter S
    Arch Toxicol; 2006 Oct; 80(10):662-70. PubMed ID: 16552503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic dependence of sulphur mustard cytotoxicity.
    Sawyer TW; Nelson P; Bjarnason S; Vair C; Shei Y; Tenn C; Lecavalier P; Burczyk A
    Toxicol Appl Pharmacol; 2010 Sep; 247(3):179-90. PubMed ID: 20600214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
    Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
    Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinjection of the nitric oxide synthase inhibitor L-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):239-47. PubMed ID: 14751418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset.
    Mackenzie GM; Jackson MJ; Jenner P; Marsden CD
    Synapse; 1997 Jul; 26(3):301-16. PubMed ID: 9183819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline.
    Lee TJ; Sarwinski S; Ishine T; Lai CC; Chen FY
    J Pharmacol Exp Ther; 1996 Feb; 276(2):353-8. PubMed ID: 8632296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
    El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
    Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase inhibition negates bombesin-induced gastroprotection.
    Castañeda AA; Kim YS; Chang LK; Cui Y; Mercer DW
    Surgery; 2000 Sep; 128(3):422-8. PubMed ID: 10965314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.